News Conference News ESC 2025 WHF Stresses the Importance of Polypills in Global Fight Against CVD Yael L. Maxwell September 09, 2025
News Features Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s? Michael O'Riordan January 17, 2025
News Daily News Improved Lipids With Gastric Bypass Linked to Surgery Itself, Not Weight Loss Michael O'Riordan July 23, 2024
News Daily News Polypills Added to List of WHO’s Essential Medicines Michael O'Riordan August 02, 2023
News Conference News ACC 2023 CRP More Predictive of Future Events Than LDL in Statin-Treated Patients Caitlin E. Cox March 14, 2023
News Daily News Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT Yael L. Maxwell February 17, 2022
News Daily News New Chest Pain Guidelines Out at Last: Most Tests Have a Role Michael O'Riordan October 28, 2021
News Daily News CAC Screening Cost-effective for Statin Decisions in Hereditary CAD Michael O'Riordan January 14, 2021
News Daily News Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans Michael O'Riordan May 15, 2020
News Daily News Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES Michael O'Riordan May 04, 2020
News Conference News ACC 2020 Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events Michael O'Riordan April 02, 2020
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Daily News Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients Michael O'Riordan August 22, 2019
News Conference News SCCT 2019 Time to Ease Up on Prior Authorization for PCSK9 Inhibitors? Yael L. Maxwell July 15, 2019
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Conference News AHA 2018 New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening Michael O'Riordan November 10, 2018
News Daily News ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom Michael O'Riordan November 07, 2018
News Daily News Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60% Michael O'Riordan October 25, 2018
News Conference News EAS 2018 ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran Yael L. Maxwell May 14, 2018